ピッツバーグ・総合病院精神医学マニュアル

出版社： 丸善出版
著者：
発行日： 2020-01-30
分野： 臨床医学：内科  >  精神医学
ISBN： 9784621304808
電子書籍版： 2020-02-28 （電子書籍版）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

6,380 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

6,380 円(税込)

購入する

商品紹介

精神科医のみならず、内科医・外科医も対象とした、コンサルテーション・リエゾン精神医学（総合病院精神医学）の包括的かつ実践的な手引書。総合病院で遭遇することの多い、精神症状・精神疾患の診断と治療について、DSM-5(精神疾患の診断･統計マニュアル第5版)に準拠して解説する。具体的な治療戦略に踏み込んだ詳述は、類書やガイドラインにはみられない本書の最大の特長。臨床での実践マニュアルとしての活用に加え、日進月歩の本領域の米国における到達点を知る上での最良のテキスト。

目次

  • 【第I部　導　入】
    　第1章　心身医学とコンサルテーション・リエゾン精神医学の歴史
    　第2章　総合病院入院診療における精神科コンサルテーション

    【第II部　一般医療現場における精神医学的診断とマネージメント】
    　第3章　一般医療現場での気分障害と不眠症
    　第4章　一般医療現場における不安
    　第5章　身体症状症および関連症群
    　第6章　一般医療現場における精神科薬物療法
    　第7章　総合病院における興奮への対応
    　第8章　一般医療現場におけるコーピングの改善と不適応行動のマネージメント
    　第9章　意思決定能力の評価

    【第III部　神経疾患およびその他の医学疾患に伴う精神症状】
    　第10章　せん妄
    　第11章　一般医療現場における神経認知障害
    　第12章　神経疾患に伴う精神症状
    　第13章　臓器不全，全身疾患に伴う精神症状

    【第IV部　医薬品使用と物質使用の緊急合併症】
    　第14章　カタトニア（緊張病），悪性症候群，セロトニン症候群
    　第15章 トキシドローム（中毒症候群）：毒物学と精神疾患患者
    　第16章 一般医療現場における物質中毒および物質離脱

    【第V部　総合病院精神医学における重要トピックス】
    　第17章　周産期精神医学
    　第18章　サイコオンコロジー
    　第19章　臓器移植精神医学
    　第20章　痛みの精神医学的評価とマネージメント
    　第21章　緩和ケアにおける精神医学
    　第22章　心身医学の将来の方向性

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

第I部 導入

P.17 掲載の参考文献
Alexander F (1950). Psychosomatic Medicine, Its Principles and Applications. New York : W. W. Norton & Company.
 
Alexander F, French TM, Ewing T (1946). Psychoanalytic Therapy : Principles and Application. New York : Ronald Press Company.
 
Alexander FG, Selesnik ST (1966). The History of Psychiatry. New York : The New American Library.
 
American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders, 5th ed. Arlington, VA : American Psychiatric Publishing.
 
Bagby RM, Parker JA, Graeme JT (1994). The 20-item Toronto-alexithymia-scale. 1 : Item selection and cross-validation of the factor structure. J Psychosom Res., 38 (1), 23-32.
 
Barsky AJ (1992). Amplification, somatization, and the somatoform disorders. Psychosomatics, 33 (1), 28-34.
PubMed
Bronheim H (2006). Psychotherapy. In Blumenfeld MS and Strain JJ (Eds.), Psychosomatic Medicine. Philadelphia : Lippincott Williams & Wilkins.
 
Flanders Dunbar H (1943). Psychosomatic Diagnosis. New York : Paul B. Hoeber.
 
Gitlin DF, Levenson JL, Lyketsos CG (2004). Psychosomatic medicine : A new psychiatric subspecialty. Acad Psychiat., 28, 1-8.
 
Hawkins DR (1982). The role of psychoanalysis in consultation-liaison psychiatry. Psychosomatics, 23 (11), 113-120.
 
Henry GW (1929). Some modern aspects of psychiatry in general hospital practice. Am J Psychiat., 86 (3), 481-499.
 
Huffman C. (Summer 2012 Edition). Philolaus. In Zalta EN (Ed.), The Stanford Encyclopedia of Philosophy. Retrieved from http://plato.stanford.edu/archives/sum2012/entries/philolaus/.
 
Huyse FJ, Herzog T, Lobo A, Malt UF, Opmeer BC, Stein B, et al. (2001). Consultation-liaison psychiatric service delivery : Results from a European study. Gen Hosp Psychiat., 23, 124-132.
 
Huyse FJ, Herzog T, Malt UF, Lobo A, the ECLW. (1996). The European consultation-liaison workgroup (ECLW) Collaborative Study : General outline. Gen Hosp Psychiat., 18, 44-55.
 
Karl SR, Holland JC (2013). Looking at the roots of psychosomatic medicine : Adolf Meyer. Psychosomatics, 54, 111-114.
 
Keefe FJ (2011). Behavioral medicine : A voyage to the future. Ann Behav Med., 41, 141-151.
 
Kiecolt-Glaser JK, McGuire L, Robles TF, Glaser R (2002). Psychoneuroimmunology and psychosomatic medicine : Back to the future. Psychosom Med., 64, 15-28.
 
Lane RD, Waldstein SR, Chesney MA, Jennings JR, Loyallo WR, Kozel PJ, et al. (2009). The rebirth of neuroscience in psychosomatic medicine, Part I : Historical context, methods, and relevant basic science. Psychosom Med., 71, 117-134.
 
Lane RD, Waldstein SR, Critchley HD, Derbyshire SW, Drossman DA, Wager TD, et al. (2009). The rebirth of neuroscience in psychosomatic medicine, Part II : Clinical applications and implications for research. Psychosom Med., 71, 135-151.
PubMed
Leentjens AFG, Lobo A (2011). On the history of European Association of Consultation-Liaison Psychiatry and Psychosomatics. J Psychosom Res., 70, 575-577.
PubMed
Lipowski ZJ (1974). Consultation-liaison psychiatry : An overview. Am J Psychiat., 131, 623-630.
PubMed
Lipowski ZJ (1986). Consultation-liaison psychiatry : The first half century. Gen Hosp Psychiat., 8, 305-315.
 
Lipowski ZJ (1992). Consultation-liaison psychiatry at century's end. Psychosomatics, 33 (2), 128-133.
PubMed
Lipsitt DR (2001). Consultation-liaison psychiatry and psychosomatic medicine : The company they keep. Psychosom Med., 63, 896-909.
PubMed
Marshall BJ, Warren JR (1984). Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet, 323 (8390), 1311-1315.
 
Overmier JB, Murison R (2013). Restoring psychology's role in peptic ulcer. Applied Psychol Health Well-Being, 5, 5-27.
 
Schwab JJ (1985). Psychosomatic medicine : Its past and present. Psychosom Med., 26 (7), 583-593.
 
Schwab JJ (1989). Consultation-liaison psychiatry : A historical overview. Psychosomatics, 30 (3), 245-254.
PubMed
Sollner W, Schussler G (2012). New 'European Association of Psychosomatic Medicine' founded. J Psychosom Res., 73, 343-344.
PubMed
Steinberg H, Herman-Lingen C (2013). Johann Christian August Heinroth : Psychosomatic medicine eighty years before Freud. Psychiat Danub., 25 (1), 11-16.
 
The Rockefeller Archive Center. 100 Years : The Rockefeller Foundation. Retrieved January 1, 2014, from http://rockefeller100.org/exhibits/show/health/psychiatry.
 
Taylor GJ, Bagby RM, Parker JD (2003). The 20-item Toronto Alexithymic Scale : IV. Reliability and factorial validity in different languages and cultures. J Psychosom Res., 55 (3), 277-283.
 
Thompson TL, Suddath RL (1987). Edward G. Billings, MD : Pioneer of consultation-liaison psychiatry. Psychosomatics, 28 (3), 153-156.
 
Wessely S, Nimnuan C, Sharpe M (1999). Functional somatic syndromes : One or many? Lancet, 354 (9182), 936-939.
PubMed
Zane MD (1947). Psychosomatic considerations in peptic ulcer. Psychosom Med., 9 (6), 372-380.
PubMed
P.34 掲載の参考文献
Anglemyer A, Horvath T, et al. (2014). The accessibility of firearms and risk for suicide and homicide victimization among household members : a systematic review and meta-analysis. Ann Intern Med., 160 (2), 101-10.
PubMed
Bronheim HE, Fulop G, et al. (1998). The Academy of Psychosomatic Medicine practice guidelines for psychiatric consultation in the general medical setting. Psychosomatics, 39 (4), S8-30.
PubMed
Centers for Disease Control and Prevention. National Suicide Statistics at a Glance. Retreived from http://www.cdc.gov/violenceprevention/suicide/statistics/index.html.
 
Choe JY, Teplin LA, et al. (2008). Perpetration of violence, violent victimization, and severe mental illness : Balancing public health concerns. Psychiatr Serv., 59 (2), 153-164.
PubMed
Desan PH, Zimbrean PC, et al. (2011). Proactive psychiatric consultation services reduce length of stay for admissions to an inpatient medical team. Psychosomatics, 52 (6), 513-520.
 
Elbogen EB, Johnson SC (2009). The intricate link between violence and mental disorder : Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiat., 66 (2), 152-161.
PubMed
Luoma JB, Martin CE, et al. (2002). Contact with mental health and primary care providers before suicide : a review of the evidence. Am J Psychiat., 159 (6), 909-916.
PubMed
Nasreddine ZS, Phillips NA, et al. (2005). The Montreal Cognitive Assessment, MoCA : a Brief Screening Tool for Mild Cognitive Impairment. J Am Geriatr Soc., 53 (4), 695-699.
 
Scott CL, Resnick PJ (2006). Violence risk assessment in persons with mental illness. Aggress Violent Beh., 11, 598-611.
 
Smith T, Gildeh N, et al. (2007). The Montreal Cognitive Assessment : Validity and utility in a memory clinic setting. Can J Psychiat., 52 (5), 329-332.
 
Swayden KJ, Anderson KK, et al. (2012). Effect of sitting vs. standing on perception of provider time at bedside : A pilot study. Patient Educ Couns., 86 (2), 166-171.
PubMed
Weiner MF, Hynan LS, et al. (2011). Luria's three-step test : What is it and what does it tell us? Int Psychogeriatr., 23 (10), 1602-1606.
 
Wei LA, Fearing MA, et al. (2008). The Confusion Assessment Method : A systematic review of current usage. J Am Geriatr Soc., 56 (5), 823-830.
 

第II部 一般医療現場における精神医学的診断とマネージメント

P.52 掲載の参考文献
Berman AL, Pomili M (Eds.) (2005). Medical Conditions Associated with Suicide Risk. Washington, DC : American Association of Suicidology. Berkman LF, Blumenthal J, et al. (2003). Effects of treating depression and low perceived social support on clinical events after myocardial infarction : The Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) randomized trial. JAMA., 289, 3106-3116.
 
Cohen BJ (Ed.) (2003). Theory and Practice of Psychiatry. New York : Oxford University Press.
 
Kendler K, Gardner C, et al. (2006). Toward a comprehensive developmental model for major depression in men. Am J Psychiat., 163 (1), 115-124.
 
Kleinman A (1991). Rethinking Psychiatry : From Cultural Category to Personal Experience. New York : The Free Press.
 
Mackinnon RA, Michels R, et al. (2006). The Psychiatric Interview in Clinical Practice. Arlington : APP.
 
Ohayon MM (2002). Epidemiology of insomnia : What we know and what we still need to learn. Sleep Med Rev., 6 (2), 97-111.
PubMed
Young JS, Bourgeois JA, et al. (2008) Sleep in hospitalized medical patients, Part 1 : Factors affecting sleep. J Hosp Med., 3 (6), 473-482.
 
Young JS, Bourgeois JA, et al. (2009) Sleep in hospitalized medical patients, Part 2 : Behavioral and pharmacological management of sleep disturbances. J Hosp Med., 4 (1), 50-59.
PubMed
P.65 掲載の参考文献
American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders, 5th ed. Arlington, VA : American Psychiatric Publishing.
 
Andrisano C, Chiesa A, et al. (2013). Newer antidepressants and panic disorder : A meta-analysis. Int Clin Psychopharmacol., 28 (1), 33-45.
PubMed
Culpepper L (2003). Use of alogorithms to treat anxiety in primary care. J Clin Psychiat., 64 (suppl 2), 30-33.
 
Denys D, van Megen HJ, et al. (2004). A double-blind switch study of paroxetine and venlafaxine in obsessive-compulsive disorder. J Clin Psychiat., 65 (1), 37-43.
 
Peacock J, Whang W (2013). Psychological distress and arrhythmia : risk prediction and potential modifiers. Prog Cardiovasc Dis., 55, 582-589.
PubMed
Pollack MH, Simon NM, et al. (2003). Combined paroxetine and clonazepam treatment strategies compared to paroxetine monotherapy for panic disorder. J Psychopharmacol., 17 (3), 276-282.
PubMed
Roy-Byrne PP, Wagner A (2004). Primary care perspectives on generalized anxiety disorder. J Clin Psychiat., 65 (suppl 13), 20-26.
 
Thurston RC, Rewak M, et al. (2013). An anxious heart : Anxiety and the onset of cardiovascular diseases. Prog Cardiovasc Dis., 55, 524-537.
PubMed
Tylee A, Walters P (2007). Underrecognition of anxiety and mood disorders in primary care : Why does the problem exist and what can be done? J Clin Psychiat., 68 (suppl 2), 27-30.
 
Wise TN (2008). Update on consultation-liaison psychiatry (psychosomatic medicine). Curr Opin Psychiat., 21 (2), 196-200.
 
P.84 掲載の参考文献
Abbey SE, Wulson L, et al. (2011). Somatization and somatoform disorders. In Levenson JL. (Ed.), The American Psychiatric Publishing Textbook of Psychosomatic Medicine : Psychiatric Care of the Medically Ill. (2nd ed., pp. 261-289.) Arlington, VA : American Psychiatric Publishing.
 
American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders, 5th ed. Arlington, VA : American Psychiatric Association.
 
Dimsdale JE, Creed F, et al. (2013). Somatic symptom disorder : An important change in DSM. J Psychosom Res., 75, 223-228.
PubMed
Eastwood S, Bisson JI (2008). Management of factitious disorders : A systematic review. Psychother Psychosom., 77 (4), 209-218.
PubMed
Fass R, Dickman R (2006). Non-cardiac chest pain : An update. Neurogastroent Motil., 18, 408-417.
PubMed
Haase E (2006). Conversion disorders. In Blumenfield M, Strain JJ (Eds.), Psychosomatic Medicine (pp. 555-564). Philadelphia : Lippincott, Williams and Wilkins.
 
Kroenke K (2007). Efficacy of treatment for somatoform disorders : A review of randomized controlled trials. Psychosom Med., 69, 881-888.
PubMed
McDermott BE, Feldman MD (2007). Malingering in the medical setting. Psychiat Clin N Am., 30, 645-662.
 
Salkovskis PM (1992). Psychological treatment of noncardiac chest pain : The cognitive approach. Am J Med., 92, 114-121.
 
Sharpe M, Peveler R, et al. (1992). The psychological treatment of patients with functional somatic symptoms : A practical guide. J Psychosom Med., 36, 515-529.
 
Strain JJ, Loigman M (2006). Hypochondriasis. In Blumenfield M, Strain JJ (Eds.), Psychosomatic Medicine (pp. 565-569). Philadelphia : Lippincott, Williams and Wilkins.
 
Straker D, Hyler S (2006). Factitious disorders. In Blumenfield M, Strain JJ (Eds.), Psychosomatic Medicine (pp. 571-578). Philadelphia : Lippincott, Williams and Wilkins.
 
Stone J, Zeman A, et al. (2002). Functional weakness and sensory disturbance. J Neurol Neurosur Ps., 73, 241-245.
 
Stonnington CM, Barry JJ, et al. (2006). Conversion disorder. Am J Psychiat., 163 (9), 1510-1517.
PubMed
Yutzy SH (2006) Somatization. In Blumenfield M, Strain JJ (Eds.), Psychosomatic Medicine (pp. 537-543). Philadelphia : Lippincott, Williams and Wilkins.
 
P.106 掲載の参考文献
Baghdady NT, Banik S, et al (2009). Psychotropic drugs and renal failure : Translating the evidence for clinical practice. Adv Ther., 26 (4), 404-424.
PubMed
Hilmer SN, McLachlan AJ, et al (2007). Clinical pharmacology in the geriatric patient. Fund Clin Pharmacol., 21, 217-230.
 
LiverTox. Clinical and Research Information on Drug-Induced Liver Injury. US National Library of Medicine. Retrieved from http://livertox.nih.gov/index.html.
 
Mackin P (2008). Cardiac side effects of psychiatric drugs. Hum Psychopharm Clin., 23 (Suppl 1), S3-S14.
 
Matzke GR, Aronoff GR, et al. (2011). Drug dosing consideration in patients with acute and chronic kidney disease-a clinical update from Kidney Disease : Improving Global Outcomes (KDIGO). Kidney Int., 80 (11), 1122-1137.
PubMed
Micromedex(R). Truven Analytics. Retrieved from http://www.micromedexsolutions.com/micromedex2/librarian/.
 
Miller AD, Smith KM (2006). Medication and nutrient administration considerations after bariatric surgery. Am J Health-Syst Ph., 63 (19), 1852-1857.
 
UpToDate(R). Wolters Kluwer Health. Retrieved from http://www.uptodate.com/contents/search.
 
Verbeeck RK (2008). Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction. Eur J Clin Pharmacol., 64, 1147-1161.
PubMed
Williams NT (2008). Medication administration through enteral feeding tubes. Am J Health-System Ph., 65 (24), 2347-2357.
 
P.120 掲載の参考文献
Levenson, JL (Ed.) (2005). Textbook of Psychosomatic Medicine. Washington, DC : American Psychiatric Publishing, Inc.
 
Wise MG, Rundell JR (2005). Clinical Manual of Psychosomatic Medicine. Washington, DC : American Psychiatric Publishing, Inc.
 
Wyszynski AA, Wyszynski B (2005). Manual of Psychiatric Care for the Medically Ill. Washington, DC : American Psychiatric Publishing.
 
P.142 掲載の参考文献
Blumen eld M, Strain JJ (Eds.) (2006). Psychosomatic Medicine. Philadelphia, PA : Lippincott, Williams, & Wilkins.
 
Gri th JL, Gaby L (2005). Brief psychotherapy at the bedside : Countering demoralization from medical illness. Psychosomatics, 46, 109-116.
 
Levenson JL (Ed.) (2009). The American Psychiatric Publishing Textbook of Psychosomatic Medicine : Psychiatric Care of the Medically Ill, 2nd ed. Arlington, VA : American Psychiatric Publishing.
 
Rollnick S, Miller WR (1995). What is motivational interviewing? Behav Cogn Psychother., 23, 325-334.
 
Stroebe M, Schut H (1999). The dual process model of coping with bereavement : rationale and description. Death Stud., 23, 197-224.
PubMed
P.156 掲載の参考文献
Appelbaum PS. (2007). Clinical practice : Assessment of patients' competence to consent to treatment. N Engl J Med., 357 (18), 1834-1840.
PubMed
Chow GV, Czarny MJ, et al. (2010). CURVES : A mnemonic for determining medical decision-making capacity and providing emergency treatment in the acute setting. Chest, 137 (2), 421-427.
PubMed
Dunn LB, Nowrangi MA, et al. (2006). Assessing decisional capacity for clinical research or treatment : A review of instruments. Am J Psychiat., 163 (8), 1323-1334.
PubMed
Ganzini L, Volicer L, et al. (2005). Ten myths about decision-making capacity. J Am Med Dir Assoc., 6 (3 Suppl), S100-104.
 
Kornfeld DS, Muskin PR, et al. (2009). Psychiatric evaluation of mental capacity in the general hospital : A significant teaching opportunity. Psychosomatics, 50 (5), 468-473.
PubMed

第III部 神経疾患およびその他の医学疾患に伴う精神症状

P.175 掲載の参考文献
Ely EW, Inouye SK, et al. (2001). Delirium in mechanically ventilated pateints : Validity and reliability of the Confusion Assessment Method for the intensive care unit (CAM-ICU). JAMA, 286 (21), 2703-2710.
 
Inouye SK, Westendorp RJ, et al. (2014). Delirium in elderly people. Lancet, 383 (9920), 911-922.
 
Lipowski ZJ. (1990). Delirium : Acute Confusional States. New York : Oxford University Press.
 
Marcantonio ER (2011). In the clinic : Delirium. Ann Intern Med., 154, ITC6 1-16.
PubMed
Maldonado JR (2013). Neuropathogenesis of delirium : Review of current etiologic theories and common pathways. Am J Geriatr Psychiat., 21, 1190-1222.
 
Meagher DJ, Moran M, et al. (2007). Phenomenology of delirium : Assessment of 100 adult cases using standardized measures. Br J Psychiat., 190, 135-141.
 
Trzepacz PT, Mittal D, et al. (2001). Validation of the Delirium Rating Scale-Revised-98 : Comparison with the Delirium Rating Scale and the Cognitive Test for Delirium. J Neuropsych Clin N., 13, 229-242.
 
Wise MG, Rundell JR (2005). Clinical Manual of Psychosomatic Medicine : A Guide to Consultation-Liaison Psychiatry. Washington, DC : American Psychiatric Publishing.
 
P.203 掲載の参考文献
American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders, 5th ed. Arlington, VA : American Psychiatric Association.
 
Kaufman DM (2001). Clinical Neurology for Psychiatrists, 5th ed. Philadelphia : W.vB. Saunders.
 
Jellinger, KA (2008). Morphologic diagnosis of "vascular dementia" : A critical update. J Neurol Sci., 270, 1-12.
PubMed
Kiloh LG (1961). Pseudo-dementia. Acta Psychiat Scand., 37 (4), 336-351.
PubMed
Lippa CF, Duda JE, et al. (2007). DLB and PDD boundary issues : Diagnosis, treatment, molecular pathology, and biomarkers. Neurology, 68, 812-819.
PubMed
McKhann GM, Knopman DS, et al. (2011). The diagnosis of dementia due to Alzheimer's disease : Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's Dement., 7, 263-269.
PubMed
Nasreddine ZS, Phillips NA, et al. (2005). The Montreal Cognitive Assessment, MoCA : A brief screening tool for mild cognitive impairment. J Am Geriatr Soc., 53 (4), 695-699.
 
Rabinovici GD, Miller BL (2010). Frontotemporal lobar degeneration. CNS Drugs, 24 (5), 375-398.
PubMed
National Institute of Neurological disorders and Stroke. NIH Stroke Scale. Rev. 10/1/2003. Retrived from http://www.ninds.nih.gov/doctors/NIH_Stroke_Scale.pdf
 
P.223 掲載の参考文献
De Groot MH, Phillips SJ, et al. (2003). Fatigue associated with stroke and other neurologic conditions : Implications for stroke rehabilitation. Arch Phys Med Rehabil., 84 (11), 1714-1720.
PubMed
Draper K, Ponsford J, et al. (2007). Psychosocial and emotional outcomes 10 years following traumatic brain injury. J Head Trauma Rehabil., 22 (5), 278-287.
PubMed
Gallego L, Barreiro P, et al. (2011). Diagnosis and clinical features of major neuropsychiatric disorders in HIV infection. AIDS Rev., 13 (3), 171-179.
PubMed
Hackett ML, Kohler S, et al. (2014). Neuropsychiatric outcomes of stroke. Lancet Neurol., 13 (5), 525-534.
PubMed
Haussleiter IS, Brune M, et al. (2009). Psychopathology in multiple sclerosis : Diagnosis, prevalence and treatment. Ther Adv Neurol Disord., 2 (1), 13-29.
PubMed
Hubers AA, Reedeker N, et al. (2012). Suicidality in Huntington's disease. J Affect Disord., 136 (3), 550-557.
PubMed
Reekum R, Stuss DT, et al. (2005). Apathy : Why care? J Neuropsychiat Clin Neurosci., 17 (1), 7-19.
 
Robert P, Onyike CU, et al. (2009). Proposed diagnostic criteria for apathy in Alzheimer's disease and other neuropsychiatric disorders. Eur Psychiat., 24 (2), 98-104.
 
Schwarzbold M, Diaz A, et al. (2008). Psychiatric disorders and traumatic brain injury. Neuropsychiatr Dis Treat., 4 (4), 797-816.
PubMed
Simpson G, Tate R (2002). Suicidality after traumatic brain injury : Demographic, injury and clinical correlates. Psychol Med., 32 (4), 87-97.
 
Tsaousides T, Cantor JB, et al (2011). Suicidal ideation following traumatic brain injury : Prevalence rates and correlates in adults living in the community. J Head Trauma Rehabil., 26 (4), 265-275.
PubMed
Whyte EM, Mulsant BH (2002). Post stroke depression : Epidemiology, pathophysiology, and biological treatment (Review). Biol Psychiat., 52 (3), 253-264.
PubMed
P.249 掲載の参考文献
Albert CM, Chae CU, et al. (2005). Phobic anxiety and risk of coronary heart disease and sudden cardiac death among women. Circulation, 111 (4), 480-487.
PubMed
Arizona Center for Education and Research on Therapeutics. List of drugs categorized by their potential to cause QT prolongation and/or torsades de pointes (n.d.) Retrieved August 8, 2014, from www.crediblemeds.org.
PubMed
Gehi A, Haas D, et al. (2005). Depression and medication adherence in outpatients with coronary heart disease : Findings from the Heart and Soul Study. Arch Intern Med, 165, 2508-2513.
PubMed
Glassman AH, O'Connor, CM, et al. (2002). Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA, 288 (6), 701-709.
PubMed
Go AS, Mozaffarian D, et al. (2013). Heart disease and stroke statistics-2013 update : A report from the American Heart Association. Circulation, 127, e6-e245.
PubMed
Jiang W, Alexander J, et al. (2001). Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med., 161, 1849-1856.
PubMed
Ko DT, Hebert PR, et al. (2002). Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction. JAMA, 288, 351-357.
PubMed
Kroenke K, Spitzer RL, et al. (2003). The Patient Health Questionnaire-2 : Validity of a two-item depression screener. Med Care, 41, 1284-1292.
PubMed
Lichtman JH, Bigger JT, Jr, et al. (2008). Depression and coronary heart disease : Recommendations for screening, referral, and treatment. Circulation, 118 (17), 1768-1775.
PubMed
Mavrides N, Nemeroff C. (2013). Treatment of depression in cardiovascular disease. Depress Anxiety, 30 (4), 328-341.
PubMed
Meijer A, Conradi HJ, et al. (2011). Prognostic association of depression following myocardial infarction with mortality and cardiovascular events : A meta-analysis of 25 years of research. Gen Hosp Psychiat., 33 (3), 203-216.
 
Murphy SL, Xu J, et al. (2013). Deaths : Final data for 2010. National Vital Statistics Report, 61 (4), 1-117.
PubMed
Pozuelo L, Tesar G, et al. (2009). Depression and heart disease : What do we know, and where are we headed? Cleve Clin J Med., 76 (1), 59-70.
PubMed
Rieckmann N, Gerin W, et al. (2006). Course of depressive symptoms and medication adherence after acute coronary syndromes : An electronic medication monitoring study. J Am Coll Cardiol., 48, 2218-2222.
PubMed
Talati A, Ponniah K, et al. (2008). Panic disorder, social anxiety disorder, and a possible medical syndrome previously linked to chromosome 13. Biol Psychiat., 63 (6), 594-601.
 
Williams W, Kunik ME, et al. (2013). Can personality traits predict the future development of heart disease in hospitalized psychiatric veterans? J Psychiatr Pract., 19 (6), 477-489.
 
Wu CK, Huang YT, et al. (2014). Anti-anxiety drugs use and cardiovascular outcomes in patients with myocardial infarction : A national wide assessment. Atherosclerosis, 235 (2), 496-502.
PubMed
Yohannes AM, Willgoss TG, et al. (2010). Depression and anxiety in chronic heart failure and chronic obstructive pulmonary disease : Prevalence, relevance, clinical implications and management principles. Int J Geriatr Psychiat., 25 (12), 1209-1221.
 
Young-Xu Y, Chan KA, et al. (2002). Long-term statin use and psychological well-being. J Am Coll Cardiol., 42, 690-697.
 
Zupancic ML (2009). Acute psychological stress as a precipitant of acute coronary syndromes in patients with undiagnosed ischemic heart disease : A case report and literature review. Prim Care Companion J Clin Psychiat., 11 (1), 21-24.
 
Akinbami LJ, Moorman JE, et al. (2012). Trends in asthma prevalence, health care use, and mortality in the United States, 2001-2010. NCHS Data Brief, 94, 1-8.
PubMed
Brenes GA (2003). Anxiety and chronic obstructive pulmonary disease : Prevalence, impact, and treatment. Psychosom Med., 65 (6), 963-970.
PubMed
Brown ES, Vornik LA, et al. (2007). Bupropion in the treatment of outpatients with asthma and major depressive disorder. Int J Psychiatry Med., 37, 23-28.
PubMed
Jain A, Lolak S (2009). Psychiatric aspects of chronic lung disease. Curr Psychiatry Rep., 11 (3), 219-225.
PubMed
Lamers F, Jonkers CC, et al. (2008). Summed score of the Patient Health Questionnaire-9 was a reliable and valid method for depression screening in chronically ill elderly patients. J Clin Epidemiol., 61, 679-687.
PubMed
Lavoie KL, Bacon SL, et al. (2006). What is worse for asthma control and quality of life : Depressive disorders, anxiety disorders, or both? Chest, 130 (4), 1039-1047.
 
Norwood R. (2006). Prevalence and impact of depression in chronic obstructive pulmonary disease patients. Curr Opin Pulm Med., 12, 113-117.
PubMed
Potoczek A, Nizankowska-Mogilnicka E, et al. (2008). Links between panic disorder, depression, defence mechanisms, coherence and family functioning in patients suffering from severe COPD. Psychiatr Pol., 42 (5), 731-748.
PubMed
Putman-Casdorph H, McCrone S (2009). Chronic obstructive pulmonary disease, anxiety, and depression : state of the science. Heart Lung, 38, 34-47.
PubMed
Roy-Byrne PP, Davidson KW, et al. (2008). Anxiety disorders and comorbid medical illness. Gen Hosp Psychiat., 30 (3), 208-225.
 
Tluczek A, Becker T, et al. (2013). Health-related quality of life in children and adolescents with cystic fibrosis : Convergent validity with parent-reports and objective measures of pulmonary health. J Dev Behav Pediatr., 34 (4), 252-261.
 
Tomioka H, Imanaka K, et al. (2007). Health-related quality of life in patients with idiopathic pulmonary fibrosis : Cross-sectional and longitudinal study. Intern Med., 46 (18), 1533-1542.
PubMed
Vozoris NT, Fischer HD, et al. (2013). Benzodiazepine use among older adults with chronic obstructive pulmonary disease : A population-based cohort study. Drugs Aging, 30 (3),183-192.
PubMed
Willgoss TG, Yohannes AM (2013). Anxiety disorders in patients with COPD : A systematic review. Respir Care, 58 (5), 858-866.
PubMed
Dundas B, Harris M, et al. (2007). Psychogenic polydipsia review : Etiology, differential, and treatment. Cur Psychiatry Rep., 9 (3), 236-241.
 
Harrison NA, Kopelman MD (2009). Endocrine diseases and metabolic disorders. In David AS, Fleminger S, Kopelman MD, Lovestone S, Mellers JDC (Eds.), Lishman's Organic Psychiatry, 4th ed. Oxford : Wiley-Blackwell.
 
Jacob S, Spinler SA (2006). Hyponatremia associated with selective serotonin reuptake inhibitors in older adults. Ann Pharmacother., 40, 1618-1622.
PubMed
Batista-Neves, SC, Quarantini LC, et al. (2008). High frequency of unrecognized mental disorders in HCV-infected patients. Gen Hosp Psychiat., 27, 431-438.
 
Castera L, Constant A, et al. (2005). Psychiatric disorders during treatment of chronic hepatitis C. Gastroenterol Clin Biol, 29, 123-133.
PubMed
Dan AA, Crone C, et al. (2007). Anger experiences among hepatitis C patients : Relationship to depressive symptoms and health-related quality of life. Psychosomatics, 48, 223-229.
PubMed
DeSanty KP, Amabile CM (2007). Antidepressant-induced liver injury. Ann Pharmacother., 41, 1201-1211.
PubMed
Ho SB, Nguyen H, et al. (2001). Influence of psychiatric diagnoses on interferon-alpha treatment for chronic hepatitis C in a veteran population. Am J Gastroenterol., 96, 157-164.
 
Hosoda S, Takimura H, et al. (2000). Psychiatric symptoms related to interferon therapy for chronic hepatitis C : Clinical features and prognosis. Psychiatry Clin Neurosci., 54, 565-572.
PubMed
Lauterbach EC, Cummings JL, et al. (1998). Neuropsychiatric correlates and treatment of lenticulostriatal diseases : A review of the literature and overview of research opportunities in Huntington's, Wilson's, and Fahr's diseases. J Neuropsychiat Clin Neurosci., 10 (3), 249-266.
 
Malek-Ahmadi P, Hilsabeck RC (2007). Neuropsychiatric complications of interferons : Classification, neurochemical bases, and management. Ann Clin Psychiat., 19, 113-123.
 
Marwick KF, Taylor M, et al. (2012). Antipsychotics and abnormal liver function tests : systematic review. Clinical Neuropharmacol., 35 (5), 244-253.
PubMed
Voican CS, Corruble E, et al. (2014). Antidepressant-induced liver injury : A review for clinicians. Am J Psychiat., 171 (4), 404-415.
PubMed
Bing EG, Burnam MA, et al. (2001). Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiat., 58, 721-728.
PubMed
Blank MB, Eisenberg MM (2013). Tailored treatment for HIV+ persons with mental illness : The intervention cascade. J Acquir Immune Defic Syndr., 63 (Suppl 1), S44-48.
 
Centers for Disease Control (CDC). (2011). HIV Surveillance Report : Diagnosis : Diagnoses of HIV Infection in the United States and Dependent Areas. Vol. 23.
 
DeHert M, Cohen D, et al. (2011). Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level. World Psychiat., 10, 138-51.
 
Heaton RK, Marcotte TD, et al. (2004). Impact of HIV-1 associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc., 10, 317-331.
PubMed
Jayarajan N, Chandra PS (2010). HIV and mental health : An overview of research from India. Indian J Psychiat., 52, S269-S273.
 
Parsons J, Rosoff E, et al. (2007). Patient-related factors predicting HIV medication adherence among men and women with alcohol problems. J Health Psychol., 12, 357-370.
 
Samet JH, Phillips SJ, et al. (2004). Detecting alcohol problems in HIV-infected patients : Use of the CAGE questionnaire. AIDS Res Hum Retroviruses, 20, 151-155.
PubMed
Turjanski N, Lloyd GG (2005). Psychiatric side-effects of medications : Recent development. Adv in Psychiatr Treat., 11, 58-70.
 
Whetten K, Reif S, et al. (2005). Substance abuse and symptoms of mental illness among HIV positive persons in the southeast. Southern Med J., 98, 9-14.
PubMed
Anderson RJ, Freedland KE, et al. (2001). The prevalence of comorbid depression in adults with diabetes, a meta-analysis. Diabetes Care, 24 (6), 1069-1078.
PubMed
Carbotte R, Denburg SD, et al. (1986). Prevalence of cognitive impairment in systemic lupus erythematosus. J Nerv Ment Dis., 174 (6), 357-364.
PubMed
David S, Fleminger MD, et al. (Eds.), Lishman's Organic Psychiatry, 4th ed. Oxford : Wiley-Blackwell.
 
Dickens C, McGowan L, et al. (2002). Depression in rheumatoid arthritis : A systematic review of the literature with meta-analysis. Psychosom Med., 64, 52-60.
PubMed
Kelly WF, Kelly MJ, et al. (2003). A prospective study of psychiatric and psychological aspects of Cushing's syndrome. Clinical Endocrinol., 45, 715-720.
 
Sadovnick AD, Eisen K, et al. (1991) Cause of death in patients attending multiple sclerosis clinics. Neurology, 41, 1193-1196.
PubMed
Schaeffer JJW, Gil KM, et al. (1999). Depression, disease severity, and sickle cell disease. J Behav Med., 22, 115-126.
 

第IV部 医薬品使用と物質使用の緊急合併症

P.275 掲載の参考文献
American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders, 5th ed. Arlington, VA : American Psychiatric Publishing.
 
Boyer EW, Shannon M (2005). The serotonin syndrome. New Eng J Med., 352 (11), 1112-1120.
PubMed
Bush G, Petrides G, et al. (1997). Catatonia and other motor syndromes in a chronically hospitalized psychiatric population. Schizophrenia Res., 27 (1), 83-92.
 
Daniels J (2009). Catatonia : Clinical aspects and neurobiological correlates. J Neuropsychiat Clin Neurosci., 21 (4), 371-380.
 
Dunkley EJ, Isbister GK, et al. (2003). The Hunter serotonin toxicity criteria : Simple and accurate diagnostic decision rules for serotonin toxicity. Quar J Med., 96 (9), 635-642.
 
Isbister GK, Bowe SJ, et al. (2004). Relative toxicity of selective serotonin reuptake inhibitors in overdose. J Toxicol Clin Toxicol., 42 (3), 277-285.
PubMed
Nisijima K, Ishiguro T (1995). Cerebrospinal fluid levels of monoamine metabolites and gamma-aminobutyric acid in neuroleptic malignant syndrome. J Psychiat Res., 29 (3), 233-244.
PubMed
Sternbach H (1991). The serotonin syndrome. Am J Psychiat., 148 (6), 705-713.
PubMed
Strawn JR, Keck PE, et al. (2007). Neuroleptic malignant syndrome. Am J Psychiat., 164 (6), 870-876.
PubMed
van der Heijden FM, Tuinier S, et al. (2005). Catatonia : Disappeared or under-diagnosed. Psychopathology, 38 (1), 3-8.
 
P.293 掲載の参考文献
Bieck PR, Antonin KH (1988). Oral tyramine pressor test and the safety of monoamine oxidase inhibitor drugs : Comparison of brofaromine and tranylcypromine in healthy subjects. J Clin Psychopharmacol., 8 (4), 237-245.
PubMed
Braverman B, McCarthy RJ, et al. (1987). Vasopressor challenges during chronic MAOI or TCA treatment in anesthetized dogs. Life Sci., 40 (26), 2587-2595.
PubMed
Brent J, Wallace KL, et al. (Eds.) (2005) Critical care toxicology : Diagnosis and management of the critically poisoned patient, Chapters 32, 39, 42, 47, 1st ed. Philadelphia : Elsevier Mosby.
 
Callaham M, Schumaker H, et al. (1988). Phenytoin prophylaxis of cardiotoxicity in experimental amitriptyline poisoning. J Pharmacol Exp Ther., 245 (1), 216-220.
PubMed
Criswell HE, Ming Z, et al. (2004). Macrokinetic analysis of blockade of NMDA-gated currents by substituted alcohols, alkanes and ethers. Brain Res., 1015 (1-2), 107-113.
 
Derlet RW, Albertson TE, et al. (1990). Antagonism of cocaine, amphetamine and methamphetamine toxicity. Pharmacol Biochem Behav., 36 (4), 745-749.
PubMed
Eddleston M, Buckley NA, et al. (2004). Speed of initial atropinisation in significant organophosphorus pesticide poisoning : A systematic comparison of recommended regimens. J Toxicol Clin Toxicol., 42 (6), 865-875.
PubMed
Espelin DE, Done AK (1968). Amphetamine poisoning : Effectiveness of chlorpromazine. N Engl J Med., 278 (25), 1361-1365.
PubMed
Gessa GL, Cuenca E, et al. (1963). On the mechanism of hypotensive effects of MAO inhibitors. Ann N Y Acad Sci., 107, 935-944.
PubMed
Gold LH, Geyer MA, et al. (1989). Neurochemical mechanisms involved in behavioral effects of amphetamines and related designer drugs. NIDA Res Monogr., 94, 101-126.
PubMed
Groves PM, Ryan LJ, et al. (1989). Neuronal actions of amphetamine in the rat brain. NIDA Res Monogr., 94, 127-145.
PubMed
Hesselink JM (1991). Safer use of MAOIs with nifedipine to counteract potential hypertensive crisis. Am J Psychiat., 148 (11), 1616.
PubMed
Hulten BA, Adams R, et al. (1992). Predicting severity of tricyclic antidepressant overdose. J Toxicol Clin Toxicol., 30 (2), 161-170.
PubMed
Liebelt EL, Francis PD, et al. (1995). ECG lead aVR versus QRS interval in predicting seizures and arrhythmias in acute tricyclic antidepressant toxicity. Ann Emerg Med., 26 (2), 195-201.
PubMed
Linden CH, Rumack BH, et al. (1984). Monoamine oxidase inhibitor overdose. Ann Emerg Med., 13 (12), 1137-1144.
PubMed
Marzuk PM, Tardiff K, Leon AC, Hirsch CS, Portera L, Iqbal MI, et al. (1998). Ambient temperature and mortality from unintentional cocaine overdose. JAMA, 279 (22), 1795-1800.
PubMed
Mowry JB, Spyker DA, et al. 2012 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS) : 30th Annual Report. Clin Toxico (l Phila), 51 (10), 949-1229.
 
Murphy MR, Blick DW, et al. (1993). Diazepam as a treatment for nerve agent poisoning in primates. Aviat Space Environ Med., 64 (2), 110-115.
PubMed
Nelson L, et al. (Eds.) (2010). Goldfrank's Toxicologic Emergencies, Chapters 13, 50, 71, 73 75, 76, 9th ed. New York : McGraw-Hill.
 
Pentel P, Peterson CD (1980). Asystole complicating physostigmine treatment of tricyclic antidepressant overdose. Ann Emerg Med., 9 (11), 588-590.
PubMed
Rabkin JG, Quitkin FM, et al. (1985). Adverse reactions to monoamine oxidase inhibitors. Part II : Treatment correlates and clinical management. J Clin Psychopharmacol., 5 (1), 2-9.
PubMed
Sasyniuk BI, Jhamandas V (1984). Mechanism of reversal of toxic effects of amitriptyline on cardiac Purkinje fibers by sodium bicarbonate. J Pharmacol Exp Ther., 231 (2), 387-394.
PubMed
Spivey WH, Roberts JR, et al. (1993). A clinical trial of escalating doses of flumazenil for reversal of suspected benzodiazepine overdose in the emergency department. Ann Emerg Med., 22 (12), 1813-1821.
PubMed
Thase ME, Trivedi MH, et al. (1995). MAOIs in the contemporary treatment of depression. Neuropsychopharmacology, 12 (3), 185-219.
PubMed
Tran TP, Panacek EA, et al. (1997). Response to dopamine vs norepinephrine in tricyclic antidepressant-induced hypotension. Acad Emerg Med., 4 (9), 864-868.
PubMed
Walker SE, Shulman KI, et al. (1996). Tyramine content of previously restricted foods in monoamine oxidase inhibitor diets. J Clin Psychopharmacol., 16 (5), 383-388.
PubMed
Youdim MB, Weinstock M (2004). Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation. Neurotoxicology, 25 (1-2), 243-250.
 
P.314 掲載の参考文献
Babor TF, Higgins-Biddle JC, et al (2001). AUDIT : The Alcohol Use Disorders Identification Test : Guidelines for use in primary care, second edition. Retrieved from http://whqlibdoc.who.int/hq/2001/WHO_MSD_MSB_01.6a.pdf.
 
Berman AH, Bergman H, et al. (2005). Evaluation of the Drug Use Disorder Identification Test (DUDIT) in criminal justice and detoxification settings in a Swedish population sample. Eur Addict Res., 11, 22-31.
 
Bradley KA, DeBenedetti AF, et al. (2007). AUDIT-C as a brief screen for alcohol misuse in primary care. Alcohol Clin Exp Res., 31 (7), 1-10.
 
Dhalla S, Kopec J. (2007). The CAGE questionnaire for alcohol misuse : A review of reliability and validity studies. Clin Invest Med N Am., 30 (1), 33-41.
 
Ewing JA (1984). Detecting alcoholism : The CAGE questionnaire. JAMA, 252 (14), 1905-1907.
PubMed
Jones HE, Kaltenbach K, et al (2010). Neonatal abstinence syndrome after methadone or buprenorphine exposure. New Engl J Med., 363 (24), 2320-2331.
PubMed
Maldonado JR, Sher Y, et al. (2014). The "Prediction of Alcohol Withdrawal Severity Scale" (PAWSS) : Systematic literature review and pilot study of a new scale for the prediction of complicated alcohol withdrawal syndrome. Alcohol, 48 (4), 375-390.
PubMed
Moeller KE, Lee KC, et al. (2008). Urine drug screening : Practical guide for clinicians. Mayo Clin Proc. 83 (1), 66-76.
PubMed
National Institute on Drug Abuse. (2009). NIDA-Modified Alcohol, Smoking and Substance Involvement Screening Test (NM-ASSIST). "NIDA-Modified ASSIST V2.0." Website accessed May 24, 2014.
 
Smith PC, Schmidt SM, et al. (2010). A single-question screening test for drug use in primary care. Arch Intern Med., 170 (13), 1155-1160.
PubMed
Spiller HA, Hays HL, et al. (2013). Overdose of drugs for attentiondeficit hyperactivity disorder : Clinical presentation, mechanisms of toxicity, and management. CNS Drugs, 27 (7) : 531-543.
PubMed
Sullivan JJ, Sykora K, et al (1989). Assessment of alcohol withdrawal : The revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict., 84, 1353-1357.
 

第V部 総合病院精神医学における重要トピックス

P.336 掲載の参考文献
Abramowitz JS, Scwhatrz SA, et al. (2003). Obsessive-compulsive symptom in pregnancy and the puerperiu : A review of the literature. J Anxiety Disord., 17, 461-478.
 
Bauer CR, Langer JC, et al. (2005). Acute neonatal e ects of cocaine exposure during preg- nancy. Arch Pediatr Adolesc Med., 159 (9), 824-834.
 
Chambers CD, Johnson KA, et al. (1996). Birth outcomes in pregnant women taking uoxetine. New Engl J Med., 335, 1010-1015.
 
Cohen LS, Altshuler LL, et al. (2006). Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA, 295 (5), 499-507.
PubMed
Cox J, Holden J, Henshaw C (2014). Perinatal Mental Health : The Edinburgh Postnatal Depression Scale Handbook, 2nd ed. London : RCPsych Publications.
 
Dunkel Schetter C, Tanner L. (2012). Anxiety, depression and stress in pregnancy : Implications for mothers, children, research and practice. Curr Opin Psychiatr., 25, 141-148.
 
Glover V, O'Connor TG, et al. (2010). Prenatal stress and programming of the HPA axis. Neurosci Biobehav Rev., 35, 17-22.
PubMed
Grote NK, Bridge JA, et al (2010). A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction. Arch Gen Psyhicat., 67 (10), 1012-1024.
PubMed
Jones HE, Kaltenback K, et al. (2010). Neonatal abstinence syndrome after methadone or buprenorphine exposure. New Engl J Med., 364 (24), 2320-2331.
 
Llewellyn A, Stowe ZN et al. (1998). The use of lithium and management of women with bipolar disorder during pregnancy and lactation. J Clin Psych., 59, s57-64.
 
Newport DJ, Calamaras MR, et al. (2007). Atypical antipsychotic administration during late pregnancy : Placental passage and obstetrical outcomes. Am J Psychiat., 164, 1214-1220.
PubMed
Newport DJ, Viguera AC, et al. (2005). Lithium placental passage and obstetrical out- come : implications for clinical management during late pregnancy. Am J Psychiat., 162 (11), 2162-2170.
 
Nulman I, Koren G, et al. (2012). Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibtors, or untreated maternal depression. Am J Psychiat., 169, 1165-1174.
PubMed
Occhigrosso M, Omran SS, et al. (2012). Persistent pumonary hypertension of the newborn and selective serotonin reuptake inhibitors : Lessons from clinical and translational studies. Am J Psychiat., 169, 134-140.
 
Robinson GE. (2012). Psychopharmacology in pregnancy and postpartum. Focus, X (1), 3-14.
 
Vigod SN, Kurdyak PA, et al. (2014). Maternal and newborn outcomes among women with schizophrenia : A restrospective population-based cohort study. BJOG, 12 (5), 566-574.
 
Wisner KL, Zarin DA, et al. (2000). Risk-bene t decision making for treatment of depression during pregnancy. Am J Psychiat., 157, 1933-1940.
 
Yonkers KA, Wisner KL, et al. (2009). The management of depression during preg-nancy : A report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. Obstet Gynecol., 114 (3), 703-713.
 
Yonkers KA, Wisner KL, Stowe Z, et al. (2004). Management of bipolar disorder during preg-nancy and the postpartum period. Am J Psychiat., 161, 608-620.
 
P.349 掲載の参考文献
Ahles T, Root J, et al. (2012). Cancer and cancer treatment-associated cognitive change : An update on the state of the science. J Clin Oncol., 30 (30), 3675-3686.
PubMed
Bush S, Bruera E (2009). The assessment and management of delirium in cancer patients. Oncologist, 14 (10), 1039-1049.
PubMed
Deprez S, Amant F, et al. (2012). Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning. J Clin Oncol., 30 (3), 274-281.
PubMed
Grossmann M, Zajac J. (2011). Management of side effects of androgen deprivation therapy. Endocrin Metab Clin N Am., 40 (3), 655-671.
 
Heinze S, Egberts F, et al. (2010). Depressive mood changes and psychiatric symptoms during 12-month low-dose interferon-alpha treatment in patients with malignant melanoma : Results from the multicenter DeCOG Trial. J Immunother., 33 (1), 106-114.
 
Herring MP, Puetz T, et al. (2012). Effect of exercise training on depressive symptoms among patients with a chronic illness : A systematic review and meta-analysis of randomized controlled trials. Arch Intern Med., 172 (2), 101-111.
PubMed
Massie MJ. (2004). Prevalence of depression in patients with cancer. J Natl Cancer I Monog., 2004 (32), 57-71.
 
McDonald B, Conroy S (2010). Gray matter reduction associated with systemic chemotherapy for breast cancer : A prospective MRI study. Breast Cancer Res Tr., 123, 819-828.
 
Miovic M, Block S (2007). Psychiatric disorders in advanced cancer. Cancer, 110 (8), 1665-1676.
PubMed
Misono S, Weiss N, et al. (2008). Incidence of suicide in persons with cancer. J Clin Oncol., 26 (29), 4631-4638.
 
Sideras K, Ingle J, et al. (2011). Coprescription of tamoxifen and medications that inhibit CYP2D6. J Clin Oncol., 28 (16), 2768-2776.
 
Spathis A, Dhillan R, et al. (2014). Modafinil for the treatment of fatigue in lung cancer : A pilot study. Palliative Med., 23 (4), 325-331.
 
Spencer RJ, Ray A, Pirl WF, Prigerson HG (2012) Clinical correlates of suicidal thoughts in patients with advanced cancer. Am J Geriat Psychiat., 20 (4), 327-336.
 
P.366 掲載の参考文献
Dew MA et al. (2007). Stress of organ transplantation. In Fink G (Ed.), Encyclopedia of Stress, 2nd ed., vol 3, pp. 35-44. Oxford : Academic Press (Elsevier).
 
DiMartini A, Dew MA, Crone C. Organ transplantation. (2009). In Kaplan, Saddock (Eds.), The Comprehensive Textbook of Psychiatry, 9th ed., vol. II, pp. 2441-2456. Philadelphia : Lippincott Williams & Wilkins.
 
DiMartini A, Sotelo J, Dew MA (2011). Organ transplantation. In Levenson J (Ed.), The American Psychiatric Press Textbook of Psychosomatic Medicine : Psychiatric Care of the Medically Ill, 2nd ed, pp. 725-758. Washington, DC : American Psychiatric Publishing.
 
DiMartini A, Crone C, Fireman M. (2010). Psychopharmacology in organ transplantation. In Ferrando, Levenson, Owen (Eds). Psychopharmacology of the Medically Ill, pp. 469-500. Washington, DC : American Psychiatric Publishing.
 
Levenson J, Olbrisch ME. (2000). Psychosocial screening and selection of candidates for organ transplantation. In Trzepacz PT, DiMartini AF (Eds.), The Transplant Patient (p. 23, pp. 21-41). Cambridge : Cambridge University Press.
 
P.384 掲載の参考文献
American Society of Anesthesiologists Task Force on Chronic Pain Management & American Society of Regional Anesthesia and Pain Medicine (2010). Practice guidelines for chronic pain management : An updated report by the American Society of Anesthesiologists Task Force on Chronic Pain Management and the American Society of Regional Anesthesia and Pain Medicine. Anesthesiology, 112 (4), 810-833.
PubMed
Attal N (2012). Neuropathic pain : Mechanisms, therapeutic approach, and interpretation of clinical trials. Continuum, 18 (1), 161-175.
PubMed
Dharmshaktu P, Tayal V, et al. (2012). Efficacy of antidepressants as analgesics : A review. J Clin Pharmacol., 52 (1), 6-17.
PubMed
Eccleston C, Morley SJ, et al. (2013). Psychological approaches to chronic pain management : Evidence and challenges. Br J Anaesth., 111 (1), 59-63.
PubMed
Fornasari D (2012). Pain mechanisms in patients with chronic pain. Clin Drug Investigat., 32 (Suppl 1), 45-52.
 
Juurlink DN, Herrmann N, et al. (2004). Medical illness and the risk of suicide in the elderly. Arch Intern Med., 164 (11), 1179-1184.
PubMed
Srinath AI, Walter C, et al. (2012). Pain management in patients with inflammatory bowel disease : Insights for the clinician. Therap Adv Gastroenterol., 5 (5), 339-357.
PubMed
P.397 掲載の参考文献
American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders, 5th ed. Arlington, VA : American Psychiatric Publishing.
 
Cappuzo M, Bertacchini S, et al. (2008). Patients with PTSD after intensive care avoid hospital contact at two-year follow-up. Acta Anaesth Scand., 15 (2), 313-314.
 
Davydow D, Katon W, et al. (2009). Psychiatric morbidity and functional impairments in survivors of burns, traumatic injuries and ICU stays for other critical illnesses : A review of the literature. Int Rev Psychiat., 21 (6), 531-538.
 
Delgado-Guay M, Parsons H, et al. (2009). Symptom distress, interventions, and outcomes of intensive care unit cancer patients referred to a palliative care consult team. Cancer, 115 (2), 437-445.
PubMed
Franzen JD, Wetzel MW, et al. (2012). Psychostimulants for older adults : Certain agents improve apathy, ADHD, depression, and other conditions. J Curr Psychiat., 11 (1), 23-32.
 
Jubran A, Lawm G, et al. (2010). Post-traumatic stress disorder after weaning from prolonged mechanical ventilation. Intens Care Med., 36 (12), 2030-2037.
 
Mundy E, Baum A (2004). Medical disorders as a cause of psychological trauma and posttraumatic stress disorder. Curr Opin Psychiat., 17 (2), 123-127.
 
Ogawa A, Shimizu K, et al. (2010). Involvement of a psychiatric consultation service in a palliative care team at the Japanese Cancer Center Hospital. Jpn J Clin Oncol., 40 (12), 1139-1146.
 
Patterson K, Croom A, et al. (2014). Current state of psychiatric involvement on palliative care consult services : Results of a national survey. J Pain Symptom Manag., 47 (6), 1019-1027.
 
Rhondali W, Reich M, et al. (2012). A brief review on the use of antidepressants in palliative care. Eur J Hosp Pharm., 19, 41-44.
 
P.415 掲載の参考文献
Ader R, Cohen N (1975). Behaviorally conditioned immunosuppression. Psychosom Med., 37, 333-342.
PubMed
Ader R, Mercurio MG, et al. (2010). Conditioned pharmacotherapeutic effects : A preliminary study. Psychosom Med., 72, 192-197.
PubMed
Antoni MH (2013). Psychosocial intervention effects on adaptation, disease course and biobehavioral processes in cancer. Brain Behav Immun., 30, S88-S98.
PubMed
Bergman LG, Fors UGH (2008). Decision support in psychiatry : A comparison between the diagnostic outcomes using a computerized decision support system versus manual diagnosis. BMC Med Inform Decis Mak., 8, 9.
PubMed
Danzer R, Kelly KW (2007). Twenty years of research on cytokine-induced sickness behavior. Brain Behav Immun., 21, 153-160.
 
Fawzy FI, Canada AL, et al. (2003). Effects of a brief, structured psychiatric intervention on survival and recurrence at 10-year followup. Arch Gen Psychiat., 60, 100-103.
PubMed
Green McDonald P, O'Connell M, et al. (2013). Psychoneuroimmunology and cancer : A decade of discovery, paradigm shifts, and methodological innovations. Brain Behav Immun., 30, S1-S9.
 
Glaser R, Kiecolt-Glaser JK (2005). Stress-induced immune dysfunction : Implication for health. Nat Rev Immunol., 5, 243-251.
PubMed
Huffman JC, Niazi SK, et al. (2014). Essential articles on collaborative care models for the treatment of psychiatric disorders in medical settings : A publication by the Academy of Psychosomatic Medicine Research and Evidence-Based Practice Committee. Psychosomatics, 55, 109-122.
PubMed
IMPACT : Evidence-based depression care (June 6, 2012). Retrieved April 12, 2014, from http://impact-uw.org/.
 
Institute for Clinical Systems Improvement (2014). Retrieved April 12, 2014, from http://www.icsi.org/.
 
Katon W, Unutzer J, et al. (2010). Collaborative depression care : History, evolution and ways to enhance dissemination and sustainability. Gen Hosp Psychiat., 32, 456-464.
 
Katon WJ (2013). Health reform and the Affordable Care Act : The importance of mental health treatment to achieving the triple aim. J Psychosom Res., 74, 533-537.
 
Korneva EA, Khai LM (1964). Effect of destruction of hypothalamic areas on immunogenesis. Fed Proc., 23, 88-92.
 
Solomon GF, Moos RH (1964). Emotions, immunity, and disease : A speculative theoretical integration. Arch Gen Psychiat., 11, 657-674.
 
Steptoe A, Hamer M, et al. (2007). The effects of acute psychological stress on circulating inflammatory factors in humans : A review and meta-analysis. Brain Behav Immun., 21, 901-912.
PubMed
TEAMcare. (2014). Retrieved April 12, 2014, from http://www.teamcarehealth.org/.
 
Trivedi MH, Kern JK, et al. (2004). A computerized clinical decision support system as a means of implementing depression guidelines. Psychiat Serv., 55, 879-885.
 
Yirmiya R, Goshen I (2011). Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain Behav Immun., 25, 181-213.
PubMed

書評

最近チェックした商品履歴

Loading...